Rockefeller Capital Management L.P. Natera, Inc. Transaction History

Rockefeller Capital Management L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 17, 2023	BUY	$36.57 - $58.29 $124,118 - $197,836	3,394 Added 164.28%	5,460 $302,000
Q4 2022 Mar 06, 2023	SELL	$34.17 - $47.91 $546 - $766	-16 Reduced 0.77%	2,066 $82,000
Q3 2022 Nov 02, 2022	BUY	$36.93 - $56.68 $55,948 - $85,870	1,515 Added 267.2%	2,082 $91,000
Q2 2022 Aug 12, 2022	SELL	$28.13 - $44.54 $200,229 - $317,035	-7,118 Reduced 92.62%	567 $19,000
Q1 2022 May 13, 2022	BUY	$30.32 - $91.33 $231,432 - $697,121	7,633 Added 14678.85%	7,685 $312,000
Q4 2021 Feb 14, 2022	BUY	$86.26 - $119.0 $2,501 - $3,451	29 Added 126.09%	52 $4,000
Q3 2021 Nov 12, 2021	BUY	$100.17 - $126.36 $601 - $758	6 Added 35.29%	23 $2,000
Q2 2021 Aug 10, 2021	SELL	$86.05 - $119.72 $22,286 - $31,007	-259 Reduced 93.84%	17 $1,000
Q1 2021 May 11, 2021	BUY	$91.47 - $124.36 $25,245 - $34,323	276 New	276 $28,000

526

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.2B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.